BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 24718553)

  • 1. Induced production of anti-etanercept antibody in collagen-induced arthritis.
    Yi H; Kim J; Jung H; Rim YA; Kim Y; Jung SM; Park SH; Ju JH
    Mol Med Rep; 2014 Jun; 9(6):2301-8. PubMed ID: 24718553
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protection against cartilage and bone destruction by systemic interleukin-4 treatment in established murine type II collagen-induced arthritis.
    Joosten LA; Lubberts E; Helsen MM; Saxne T; Coenen-de Roo CJ; Heinegård D; van den Berg WB
    Arthritis Res; 1999; 1(1):81-91. PubMed ID: 11056663
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CEL-2000: A therapeutic vaccine for rheumatoid arthritis arrests disease development and alters serum cytokine/chemokine patterns in the bovine collagen type II induced arthritis in the DBA mouse model.
    Zimmerman DH; Taylor P; Bendele A; Carambula R; Duzant Y; Lowe V; O'Neill SP; Talor E; Rosenthal KS
    Int Immunopharmacol; 2010 Apr; 10(4):412-21. PubMed ID: 20074669
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combined effects of bucillamine and etanercept on a rat type II collagen-induced arthritis model.
    Setoguchi C; Tsuji F; Katsuta O; Okamoto M; Aono H
    Mod Rheumatol; 2010 Aug; 20(4):381-8. PubMed ID: 20379758
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Etanercept attenuates collagen-induced arthritis by modulating the association between BAFFR expression and the production of splenic memory B cells.
    Wang QT; Wu YJ; Huang B; Ma YK; Song SS; Zhang LL; Chen JY; Wu HX; Sun WY; Wei W
    Pharmacol Res; 2013 Feb; 68(1):38-45. PubMed ID: 23178558
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Kirenol exerts a potent anti-arthritic effect in collagen-induced arthritis by modifying the T cells balance.
    Lu Y; Xiao J; Wu ZW; Wang ZM; Hu J; Fu HZ; Chen YY; Qian RQ
    Phytomedicine; 2012 Jul; 19(10):882-9. PubMed ID: 22673798
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Murine analogues of etanercept and of F8-IL10 inhibit the progression of collagen-induced arthritis in the mouse.
    Doll F; Schwager K; Hemmerle T; Neri D
    Arthritis Res Ther; 2013 Sep; 15(5):R138. PubMed ID: 24289726
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Kinsenoside inhibits the inflammatory mediator release in a type-II collagen induced arthritis mouse model by regulating the T cells responses.
    Hsiao HB; Hsieh CC; Wu JB; Lin H; Lin WC
    BMC Complement Altern Med; 2016 Feb; 16():80. PubMed ID: 26916550
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interleukin-20 antibody is a potential therapeutic agent for experimental arthritis.
    Hsu YH; Chang MS
    Arthritis Rheum; 2010 Nov; 62(11):3311-21. PubMed ID: 20722035
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A tumor necrosis factor receptor loop peptide mimic inhibits bone destruction to the same extent as anti-tumor necrosis factor monoclonal antibody in murine collagen-induced arthritis.
    Saito H; Kojima T; Takahashi M; Horne WC; Baron R; Amagasa T; Ohya K; Aoki K
    Arthritis Rheum; 2007 Apr; 56(4):1164-74. PubMed ID: 17393436
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of tumor necrosis factor-related apoptosis-inducing ligand on the reduction of joint inflammation in experimental rheumatoid arthritis.
    Jin CH; Chae SY; Kim TH; Yang HK; Lee EY; Song YW; Jo DG; Lee KC
    J Pharmacol Exp Ther; 2010 Mar; 332(3):858-65. PubMed ID: 19933369
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The pharmacology study of a new recombinant TNF receptor-hyFc fusion protein.
    Lee JH; Cho JH; Yeo J; Lee SH; Yang SH; Sung YC; Kang JH; Park CS
    Biologicals; 2013 Mar; 41(2):77-83. PubMed ID: 23190454
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Significant associations of antidrug antibody levels with serum drug trough levels and therapeutic response of adalimumab and etanercept treatment in rheumatoid arthritis.
    Chen DY; Chen YM; Tsai WC; Tseng JC; Chen YH; Hsieh CW; Hung WT; Lan JL
    Ann Rheum Dis; 2015 Mar; 74(3):e16. PubMed ID: 24442879
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The suppressive effects of Saposhnikovia divaricata (Fangfeng) chromone extract on rheumatoid arthritis via inhibition of nuclear factor-κB and mitogen activated proteinkinases activation on collagen-induced arthritis model.
    Kong X; Liu C; Zhang C; Zhao J; Wang J; Wan H; Zhu H; Zhang P; Chen W; Xiao Y; Lin N
    J Ethnopharmacol; 2013 Jul; 148(3):842-50. PubMed ID: 23711830
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Copernican revolution in the therapy of rheumatoid arthritis: the contribution of anti-TNFalpha drugs].
    Bombardieri S; Ferraccioli G; Ferri C; Galeazzi M; Lapadula G; Cerinic MM; Montecucco C; Triolo G; Trotta F; Valentini G
    Reumatismo; 2009; 61 Suppl 1():1-23. PubMed ID: 19999184
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibitory effects of the root extract of Dipsacus asperoides C.Y. Cheng et al T.M.Ai on collagen-induced arthritis in mice.
    Jung HW; Jung JK; Son KH; Lee DH; Kang TM; Kim YS; Park YK
    J Ethnopharmacol; 2012 Jan; 139(1):98-103. PubMed ID: 22041103
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of pristane-induced arthritis, a murine model of chronic disease: response to antirheumatic agents, expression of joint cytokines, and immunopathology.
    Patten C; Bush K; Rioja I; Morgan R; Wooley P; Trill J; Life P
    Arthritis Rheum; 2004 Oct; 50(10):3334-45. PubMed ID: 15476226
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibitory effects of a traditional Chinese herbal formula TBL-II on type II collagen-induced arthritis in mice.
    Shen X; Li C; Zhao H; Li S; Chen J; Kobayashi Y; Shen W
    J Ethnopharmacol; 2011 Mar; 134(2):399-405. PubMed ID: 21215307
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adalimumab, etanercept, and infliximab utilization patterns and drug costs among rheumatoid arthritis patients.
    Carter CT; Changolkar AK; Scott McKenzie R
    J Med Econ; 2012; 15(2):332-9. PubMed ID: 22168788
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment with a neutralizing anti-murine interleukin-17 antibody after the onset of collagen-induced arthritis reduces joint inflammation, cartilage destruction, and bone erosion.
    Lubberts E; Koenders MI; Oppers-Walgreen B; van den Bersselaar L; Coenen-de Roo CJ; Joosten LA; van den Berg WB
    Arthritis Rheum; 2004 Feb; 50(2):650-9. PubMed ID: 14872510
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.